Showing results (141-150 of 208) with videos related to

Sort By:
Pageof 21
Open Veterinary Journal|June 2, 2025
Newcastle disease virus in Egyptian domestic poultry, 2019-2021: Molecular characterization, phylogenetic analysis, and coinfection with avian influenza A virusAhmed El Taweel, Mohamed El Sayes, Asmaa Maatouq, et al.
Poultry Science|December 18, 2012
Do commercial avian influenza H5 vaccines induce cross-reactive antibodies against contemporary H5N1 viruses in Egypt?G Kayali, A Kandeil, R El-Shesheny, et al.
Plos One|June 29, 2022
Incidence and neutralizing antibody seroprevalence of influenza B virus in Egypt: Results of a community-based cohort studyNoura M Abo Shama, Sara H Mahmoud, Ola Bagato, et al.
AIDS (London, England)|July 1, 2011
Cervical HIV-1 RNA shedding after cryotherapy among HIV-positive women with cervical intraepithelial neoplasia stage 2 or 3Michael H Chung, Kevin P McKenzie, Barbra A Richardson, et al.
Journal of Traumatic Stress|November 11, 2005
War zone stress without direct combat: the Australian naval experience of the Gulf WarJillian F Ikin, Dean P McKenzie, Mark C Creamer, et al.
Current HIV Research|May 19, 2011
Cervical squamous intraepithelial lesions among HIV-positive women on antiretroviral therapy in KenyaKevin P McKenzie, Robyn K Rogers, Julia W Njoroge, et al.
AIDS (London, England)|July 12, 2013
Comparing Papanicolau smear, visual inspection with acetic acid and human papillomavirus cervical cancer screening methods among HIV-positive women by immune status and antiretroviral therapyMichael H Chung, Kevin P McKenzie, Hugo De Vuyst, et al.
Emerging Microbes & Infections|August 28, 2024
Highly pathogenic avian influenza virus H5N1 clade 2.3.4.4b in wild rats in Egypt during 2023Omnia Kutkat, Mokhtar Gomaa, Yassmin Moatasim, et al.
Emerging Infectious Diseases|December 17, 2011
Continuing threat of influenza (H5N1) virus circulation in EgyptGhazi Kayali, Rabeh El-Shesheny, Mohamed A Kutkat, et al.
International Journal of Cancer|June 20, 2024
Five-year outcomes of fractionated stereotactic body radiotherapy for oligometastatic prostate cancer from the TRANSFORM phase II trialAndrew W See, Paul Conway, Mark Frydenberg, et al.
Pageof 21